Short-term carnitine deficiency does not alter aerobic rat heart function but depresses reperfusion recovery after ischemia

Canadian Journal of Physiology and Pharmacology

Volumn 79, Issue 10, 2001, Pages 892-897

  Broderick, T L ^a   Cifuentes, J ^a   Green, D ^a   Paulson, D J ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Cardiac; Carnitine deficiency; Ischemia; Pivalate; Reperfusion

Indexed keywords

CARNITINE; SODIUM DERIVATIVE; SODIUM PIVALATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARNITINE DEFICIENCY; CONTROLLED STUDY; DISEASE DURATION; DISEASE PREDISPOSITION; HEART FUNCTION; HEART LEFT ATRIUM PRESSURE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE RELAXATION; HEART MUSCLE REPERFUSION; HEART OUTPUT; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE LEVEL;

EID: 0034767821     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y01-051     Document Type: Article

References (23)

1. Impaired ketogenesis in carnitine depletion caused by short-term administration of pivalic acid prodrug
2. Effect of short-term treatment with pivalic acid containing antibiotics on serum carnitine concentration: A risk irrespective of age
3. Transient reduction of human left ventricular mass in carnitine depletion induced by antibiotics containing pivalic acid
4. Pivalic acid-induced carnitine deficiency and physical exercise in humans
5. Sodium pivalate reduces tissue carnitines and enhances ketosis in rats
6. Carnitine-metabolism and functions
7. Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a period of global ischemia is accompanied by a stimulation of glucose oxidation
8. Fatty acid oxidation and cardiac function in the sodium pivalate model of secondary carnitine deficiency
9. L-propionylcarnitine effects on cardiac carnitine content and function in secondary carnitine deficiency
10. L-carnitine improvement of cardiac function is associated with a stimulation in glucose but not fatty acid oxidation in carnitine-deficient hearts
11. L-carnitine increases glucose metabolism and mechanical function following ischaemia in diabetic rat heart
12. Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions
13. Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy
14. Recovery of ventricular function in reperfused ischemic rat hearts exposed to fatty acids
15. Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats
16. Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine
17. An improved and simplified radioisotopic assay for the determination of free and esterfied carnitine
18. Role of glycolystic products in damage to ischemic mycardium
19. Effect of pressure development on oxygen consumption by isolated rat heart
20. Carnitine deficiency-induced cardiomyopathy
21. Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases
22. Effect of L-carnitine on lipid metabolism and cardiac performance in chronically diabetic rats
23. Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia